CD8A and neoplasm: Indeed, as noted earlier, both PD-1 and CTLA-4 are required for peripheral CD8+ T cell tolerance, so disrupting these pathways during checkpoint blockade should globally impair peripheral tolerance against both non-tumor and tumor-derived antigens (Figure 3).